CymaBay Therapeutics, Inc.
Industry: Life Sciences ・ $CBAY on Nasdaq
Insider Sale
+$249,641
-12.81%
Shares
Shares Volume: 15,921 Shares
Average Share Price: $15.68
INSIDER
EMSTER KURT VON
Director
reported on Sep 29 2023
traded on Sep 29 2023
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 108,406 |
| PURCHASES/SALES 1Y | 0 / 1 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $249,641.28 |
| INSIDER PREVIOUS TRADES | No trades in past 1Y |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 4 |
| PURCHASES/SALES 1Y | 0 / 16 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $247,556.91 |
| COMPANY PREVIOUS TRADES |